Already a member? Sign in
Category: Prescription Drugs
Intravenous (IV) steroids are used to treat an acute MS attack also known as an exacerbation or relapse. They are generally given daily for three to five days. IV steroids such as Solu-Medrol (methylprednisolone) are used to hasten the recovery from the relapse.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| MS (Multiple Sclerosis) | 124 | 52 |
|
|
|
|
|
| Relapse MS (exacerbation) | 45 | 20 |
|
|
|
|
|
| Other | 38 | 12 |
|
|
|
||
| Vision | 31 | 9 |
|
|
|
||
| Improve mobility | 19 | 5 |
|
|
|||
| Stiffness/Spasticity | 16 | 6 |
|
|
|
See all 104 patients currently taking Steroid IV Infusion
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Steroid IV Infusion
| Metallic taste in mouth | 33 | |
|---|---|---|
| Flushed | 25 | |
| Blush | 25 | |
| Overheated | 25 | |
| Weight gain | 24 | |
| Fatigue | 18 | |
| See all 63 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Steroid IV Infusion. See all 49 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Course of treatment ended | 209 | ||
| Doctor's advice | 29 | ||
| Did not seem to work | 14 | ||
| Other | 13 | ||
| Side effects too severe | 12 | ||
| Not indicated | 3 | ||
| Personal research | 1 | ||
| Expense | 1 |
See all 249 patients who’ve stopped taking Steroid IV Infusion
Adherence
Taking treatment as prescribed
Adherence of Steroid IV Infusion
Always |
97 | 87% |
|
|---|---|---|---|
Usually |
4 | 4% |
|
Sometimes |
3 | 3% |
|
Never |
7 | 6% |
|
Burden
Difficulty being on treatment
Burden of Steroid IV Infusion
Very |
16 | 14% |
|
|---|---|---|---|
Somewhat |
29 | 26% |
|
A little |
35 | 32% |
|
Not at all |
31 | 28% |
|
Cost
Paid out of pocket
Cost of Steroid IV Infusion
$200+ |
16 | 29% |
|
|---|---|---|---|
$100-199 |
3 | 5% |
|
$50-99 |
3 | 5% |
|
$25-49 |
3 | 5% |
|
< $25 |
30 | 55% |
|
Report created on February 12, 2012.